From: [18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer
Cell lines
MDA-MB-231
MDA-MB-468
Epirubicin
1.54 ± 0.02
0.025 ± 0.0002
Paclitaxel
0.02 ± 0.007
0.0035 ± 0.0005